Incorporation and metabolic conversion of erucic acid in various tissues of the rat in short term experiments

Rats were intravenously injected with a mixture of free (14-¹⁴C) erucic acid (22∶1) and (9–10³H) oleic acid (18∶1). After 2, 4, 8, 16, and 30 min, radioactivity was examined in blood, liver, heart, kidneys, and spleen. Free (¹⁴C) 22∶1 disappeared from the blood more rapidly than free (¹⁴C) 18∶1 between 0 and 8 min. Incorporation of label into triglycerides only appeared after 16 min and at 30 min they represented 4% of the injected radioactivity. In this fraction, 63% of¹⁴C radioactivity was present as 18∶1 and not as the original 22∶1, while almost all³H radioactivity was recovered as unchanged 18∶1. At all times studied, the majority of radioactivity was found in the liver, primarily as triglycerides (60% of radioactivity in total lipids) and as phospholipids (20–30%).¹⁴C was present in nearly the same proportion as³H (13% of injected radioactivity after only 2 min, 11% at 30 min).¹⁴C radioactivity was contained in 18∶1 in higher proportion than 22∶1 (45% in triglycerides, 65% in phospholipids). Since labeled triglycerides of blood, rich in (¹⁴C) 18∶1, mainly originate from the liver triglycerides, it appears that 18∶1 is the major form of utilization of 22∶1 in the tissues after its conversion in liver. In the other organs tested, radioactivity was found 10–15 times lower than in liver. In the heart,¹⁴C was 3 to 4 times higher than³H. More than 80% was recovered as 22∶1 in triglycerides. In spleen and kidneys, the¹⁴C:³H ratio was particularly high in free fatty acids and monoglycerides. In kidneys, 60% of¹⁴C was present as nervonic acid (24∶1) in monoglycerides and 40% in phospholipids, suggesting that the mononervonin formed was used for phospholipid biosynthesis. A preliminary report of this work was presented at the 10th International Congress of Nutrition, Kyoto, Japan, August 1975.